Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value:
$2.87B
Total Bought:
$695.65M
Total Sold:
$383.53M
Net Transaction:
+$312.12M
Notable People:
Dr. Senai Nmn Asefaw
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc5,000,0005,363,379+363,379$511.50M$419.85M14.61%-$91.65M
Arcellx Inc
COMMON STOCK
4,000,0004,371,601+371,601$334.04M$335.26M11.66%+$1.22M
argenx SEADR(ARGX)480,374481,305+931$260.40M$296.00M10.30%+$35.60M
Revolution Medicines, Inc.(RVMD)5,314,0896,553,111+1,239,022$240.99M$286.63M9.97%+$45.64M
Janux Therapeutics, Inc.(JANX)2,400,5743,515,986+1,115,412$109.06M$188.25M6.55%+$79.19M
Tarsus Pharmaceuticals, Inc.(TARS)2,440,4452,531,896+91,451$80.27M$140.19M4.88%+$59.92M
Edgewise Therapeutics, Inc.(EWTX)2,789,1724,493,929+1,704,757$74.44M$119.99M4.17%+$45.54M
Vaxcyte, Inc.(PCVX)627,7321,422,787+795,055$71.73M$116.47M4.05%+$44.74M
BeOne Medicines AGADR(ONC)200,336616,024+415,688$44.98M$113.79M3.96%+$68.81M
Crinetics Pharmaceuticals In2,516,6861,910,761-605,925$128.60M$97.70M3.40%-$30.91M
MoonLake ImmunotherapeuticsCL A(MLTX)931,4801,772,211+840,731$46.97M$95.97M3.34%+$49.00M
Disc Medicine, Inc.(IRON)1,497,7201,497,7200$73.60M$94.96M3.30%+$21.36M
Merus N V2,454,9171,689,922-764,995$122.65M$71.06M2.47%-$51.59M
Vera Therapeutics, Inc.CL A(VERA)1,096,8511,437,339+340,488$48.48M$60.79M2.11%+$12.30M
Apogee Therapeutics Inc701,8171,283,766+581,949$41.22M$58.15M2.02%+$16.93M
Olema Pharmaceuticals, Inc.(OLMA)5,503,6007,304,970+1,801,370$65.71M$42.59M1.48%-$23.13M
Pliant Therapeutics, Inc.(PLRX)3,104,4863,197,050+92,564$34.80M$42.11M1.46%+$7.30M
Immatics N.V.SHS(IMTX)3,904,8625,414,409+1,509,547$44.55M$38.50M1.34%-$6.06M
Cogent Biosciences, Inc.(COGT)4,609,7624,917,412+307,650$49.79M$38.36M1.33%-$11.43M
Spyre Therapeutics, Inc.(SYRE)1,267,5811,527,205+259,624$37.28M$35.55M1.24%-$1.73M
Viridian Therapeutics, Inc.(VRDN)2,895,6891,820,079-1,075,610$65.88M$34.89M1.21%-$30.99M
Y-Mabs Therapeutics Inc4,086,3464,236,346+150,000$53.74M$33.17M1.15%-$20.56M
Erasca, Inc.(ERAS)10,668,14110,752,354+84,213$29.12M$26.99M0.94%-$2.14M
Tectonic Therapeutic, Inc.(TECX)0485,105+485,105$0$22.40M0.78%+$22.40M
LENZ Therapeutics, Inc.(LENZ)0770,455+770,455$0$22.24M0.77%+$22.24M
Scholar Rock Holding Corporation(SRRK)0400,000+400,000$0$17.29M0.60%+$17.29M
Oruka Therapeutics, Inc.(ORKA)719,660819,660+100,000$17.64M$15.89M0.55%-$1.75M
Agios Pharmaceuticals, Inc.(AGIO)0276,439+276,439$0$9.08M0.32%+$9.08M
Arvinas, Inc.(ARVN)2,339,9610-2,339,961$57.63M$0—-$57.63M
COMPASS Pathways plcADS(CMPS)1,160,0000-1,160,000$7.31M$0—-$7.31M
Cullinan Therapeutics, Inc.(CGEM)2,321,0130-2,321,013$38.85M$0—-$38.85M
Immunovant, Inc.(IMVT)1,362,8270-1,362,827$38.85M$0—-$38.85M
Keros Therapeutics, Inc.(KROS)525,0370-525,037$30.49M$0—-$30.49M
Kura Oncology, Inc.(KURA)4,331,3210-4,331,321$84.63M$0—-$84.63M
Perspective Therapeutics, Inc.(CATX)919,6920-919,692$12.28M$0—-$12.28M
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q4 2024 | TickerTrail